Ray is our Principal based in Shanghai office, covering healthcare consulting business. He successfully served MNCs clients such as Roche, AstraZeneca, DSPC, MTPC and Medtronic, and domestic clients such as Guangxi Healthcare Investment Group, GenSci Pharma Co. etc.
Prior to joining Author D. Little, Ray worked with EY Parthenon for 4.5 years as Senior Manager, Roland Berger for 2.5 years as Consultant and ZS Associates for 2 years.

Ray is an expert on the following healthcare industry topics:
Corporate strategy planning, including 14th 5-year strategy planning and organization restructure for Guangxi healthcare investment group, Pediatrics and child health business strategy planning for GenSci Pharma Co., etc.
Market entry and new product launch, including Fasinumab and Vadadustat new product launch planning for MTPC China, Forxiga and Onglyza new product launch planning for AstraZeneca China, etc.
Sales force planning and channel management, including Market research and channel planning of orthopedics broad market business for Medtronic China, Corporate productivity improvement project for Roche China, etc.
Healthcare industrial planning related topics

Now Ray is paying much attention at following topics:
MNCs’ New China business model study
New capitalization method and commercialization model for China Biotech and start-ups
R&D and biotech related M&A service for China domestic giants (including SOEs) 
Digital health, digital medicine and digital therapeutics (DTx) transformation for healthcare service providers in China